Latest Asx News

DMC Mining Limited reports steady progress on its Guinea projects’ licences amid ongoing ASX re-admission efforts, despite critically low cash reserves.

Freehill Mining Limited has addressed an ASX query over the late filing of a director’s interest notice, attributing the delay to an administrative oversight and reaffirming its compliance protocols.

Arafura Rare Earths has made decisive strides in funding its Nolans Project, securing up to US$400 million in conditional and indicative investments from Australian and US government-linked financiers, alongside a strong equity raise.

Macro Metals Limited has bolstered its financial position with a $2 million capital raise while making significant progress across its iron ore and construction sand projects, underpinned by strong Indigenous joint ventures and mining services development.

Klevo Rewards Limited reports a strong quarter with a tenfold increase in customer receipts and positive cash flow, completing a $3.4 million entitlement offer and advancing steps toward ASX reinstatement.

Taiton Resources has successfully issued 5 million new shares to sophisticated investors, marking the completion of its Tranche 1 placement and reinforcing its funding position for key mineral projects.

Enterprise Metals reports encouraging preliminary gold assay results from its recent drilling at the Vulcan Prospect within the Doolgunna Project, highlighting significant near-surface mineralisation and potential for a substantial gold deposit.

Tesoro Gold Limited has announced plans for a 15-for-1 share consolidation aimed at simplifying its capital structure and enhancing its appeal to investors, pending shareholder approval at the November 26 meeting.

Assetora Limited has reopened its flagship fund under a new name, secured a $3 million strategic investment, and reported its first positive operating cashflow since adopting its fund-management model.

Carbonxt Group Limited has advanced its Kentucky activated carbon facility ownership to 45.9%, with kiln commissioning underway and a projected 200% sales increase. The company also raised $1.3 million to support growth amid strong regulatory demand for PFAS filtration products.

Radiopharm Theranostics has secured FDA approval to initiate a Phase I trial targeting B7H3 and raised A$40 million to accelerate its radiopharmaceutical programs. The company also appointed renowned oncologist Dr Oliver Sartor to its Scientific Advisory Board.

Domino’s Pizza Enterprises has responded to an ASX price query following a sharp rise in its share price and trading volume, denying any undisclosed acquisition talks despite market speculation.